- Stocks
- Healthcare
- NYSE: TMO

Price (delayed)

$520.14

Market cap

$200.63B

P/E Ratio

33.69

Dividend/share

$1.25

EPS

$15.44

Enterprise value

$232.4B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .

Thermo Fisher Scientific's revenue has increased by 7% YoY but it has decreased by 2.5% from the previous quarter

The company's equity fell by 3.9% QoQ but it rose by 3.2% YoY

Thermo Fisher Scientific's quick ratio has decreased by 27% from the previous quarter and by 18% YoY

Thermo Fisher Scientific's net income has decreased by 21% YoY and by 13% from the previous quarter

What are the main financial stats of TMO

Market
Valuations
Earnings

Shares outstanding

385.72M

Market cap

$200.63B

Enterprise value

$232.4B

Price to earnings (P/E)

33.69

Price to book (P/B)

4.74

Price to sales (P/S)

4.58

EV/EBIT

31.57

EV/EBITDA

21.63

EV/Sales

5.31

Revenue

$43.81B

EBIT

$7.36B

EBITDA

$10.74B

Free cash flow

$5.65B

Per share
Balance sheet
Liquidity

EPS

$15.44

Free cash flow per share

$14.63

Book value per share

$109.64

Revenue per share

$113.49

TBVPS

$86.91

Total assets

$94.66B

Total liabilities

$52.35B

Debt

$35.26B

Equity

$42.26B

Working capital

$4.33B

Debt to equity

0.83

Current ratio

1.27

Quick ratio

0.72

Net debt/EBITDA

2.96

Margins
Efficiency
Dividend

EBITDA margin

24.5%

Gross margin

40.3%

Net margin

13.8%

Operating margin

16.3%

Return on assets

6.5%

Return on equity

14%

Return on invested capital

15.3%

Return on capital employed

9.3%

Return on sales

16.8%

Dividend yield

0.24%

DPS

$1.25

Payout ratio

8.1%

How has the Thermo Fisher Scientific stock price performed over time

Intraday

0.15%

1 week

-0.36%

1 month

-4.35%

1 year

-8.76%

YTD

-5.55%

QTD

-9.76%

How have Thermo Fisher Scientific's revenue and profit performed over time

Revenue

$43.81B

Gross profit

$17.65B

Operating income

$7.14B

Net income

$6.02B

Gross margin

40.3%

Net margin

13.8%

Thermo Fisher Scientific's operating margin has decreased by 32% YoY and by 13% from the previous quarter

The operating income has contracted by 27% YoY and by 15% from the previous quarter

The net margin has decreased by 25% YoY and by 11% QoQ

Thermo Fisher Scientific's net income has decreased by 21% YoY and by 13% from the previous quarter

What is Thermo Fisher Scientific's growth rate over time

What is Thermo Fisher Scientific stock price valuation

P/E

33.69

P/B

4.74

P/S

4.58

EV/EBIT

31.57

EV/EBITDA

21.63

EV/Sales

5.31

TMO's EPS is down by 20% year-on-year and by 13% since the previous quarter

The stock's price to earnings (P/E) is 7% more than its last 4 quarters average of 31.4 and 6% more than its 5-year quarterly average of 31.6

The P/B is 5% below the last 4 quarters average of 5.0

The company's equity fell by 3.9% QoQ but it rose by 3.2% YoY

The P/S is 8% below the 5-year quarterly average of 5.0 and 7% below the last 4 quarters average of 4.9

Thermo Fisher Scientific's revenue has increased by 7% YoY but it has decreased by 2.5% from the previous quarter

How efficient is Thermo Fisher Scientific business performance

TMO's return on invested capital is down by 29% year-on-year and by 12% since the previous quarter

TMO's ROA is down by 29% YoY and by 13% from the previous quarter

The ROE has contracted by 27% YoY and by 14% from the previous quarter

TMO's ROS is down by 24% year-on-year and by 10% since the previous quarter

What is TMO's dividend history

DPS

$1.25

Dividend yield

0.24%

Payout ratio

8.1%

Recent dividends

How did Thermo Fisher Scientific financials performed over time

The total assets is 81% greater than the total liabilities

Thermo Fisher Scientific's quick ratio has decreased by 27% from the previous quarter and by 18% YoY

The current ratio has declined by 19% year-on-year and by 14% since the previous quarter

The debt is 17% lower than the equity

Thermo Fisher Scientific's debt to equity has increased by 6% QoQ and by 2.5% YoY

The debt has increased by 6% YoY and by 2.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.